Aquatic Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Aquatic Capital Management’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$210K	Buy	4,369 +2,430	+125%	+$108K	0.01%	972
2025 Q4	$80K	Buy	+1,939	New	+$77.8K	﹤0.01%	1206
2024 Q3	–	Sell	-11,000	Closed	-$205K	–	1357
2024 Q2	$205K	Buy	11,000 +500	+5%	+$9.37K	0.01%	748
2024 Q1	$207K	Buy	10,500 +1,900	+22%	+$37.1K	0.01%	757
2023 Q4	$151K	Buy	+8,600	New	+$141K	﹤0.01%	913
2023 Q2	–	Sell	-600	Closed	-$6K	–	1559
2023 Q1	$6K	Sell	600 -3,300	-85%	-$43.5K	﹤0.01%	1155
2022 Q4	$58K	Sell	3,900 -6,600	-63%	-$96.1K	﹤0.01%	989
2022 Q3	$135K	Buy	+10,500	New	+$120K	0.01%	689
2022 Q2	–	Sell	-200	Closed	-$2K	–	1399
2022 Q1	$2K	Buy	+200	New	+$2.12K	﹤0.01%	968

Other funds holding KNSA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Aquatic Capital Management's KNSA Position: Q1 2026 in Review

Aquatic Capital Management increased its Kiniksa Pharmaceuticals (KNSA) stake by 125% in Q1 2026, buying an estimated $108K and bringing the position to 4,369 shares worth $210K. The position accounts for 0.01% of the portfolio, ranked #972.

Aquatic Capital Management first reported a position in KNSA in Q1 2022 and has held it in 9 quarters since. 228 funds tracked by Wall St. Rank hold KNSA as of Q1 2026.

Aquatic Capital Management held 4,369 shares of Kiniksa Pharmaceuticals worth $210K as of Q1 2026.
Aquatic Capital Management bought 2,430 Kiniksa Pharmaceuticals shares in Q1 2026, an estimated $108K.
Kiniksa Pharmaceuticals made up 0.01% of Aquatic Capital Management's portfolio in Q1 2026, its #972 holding.
Aquatic Capital Management first reported a position in Kiniksa Pharmaceuticals in Q1 2022 and has held it in 9 quarters since.
228 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.